Ipamorelin

Ipamorelin (10 mg) is a synthetic peptide investigated in research for its selective activity on growth hormone secretagogue receptors (GHS-R1a), which are involved in the regulation of growth hormone release and metabolic signalling. It functions as a ghrelin receptor agonist, meaning it mimics the action of ghrelin in stimulating pulsatile growth hormone secretion under controlled laboratory conditions.

In research settings, Ipamorelin is characterised by its high receptor selectivity, as it has been observed to stimulate growth hormone release with minimal interaction with other hormonal pathways, such as cortisol or prolactin, compared to earlier growth hormone secretagogues. This selective profile makes it a compound of interest in studies examining endocrine signalling and regulatory mechanisms.

Ipamorelin has also been investigated for its potential influence on processes related to tissue repair, metabolic regulation, and cellular turnover in experimental models. Additionally, it is studied in the context of appetite signalling and energy balance due to its interaction with ghrelin pathways.

Owing to this targeted mechanism of action, Ipamorelin is used in laboratory research as a model compound for exploring growth hormone dynamics, metabolic function, and neuroendocrine regulation.